In the ongoing battle against pathogens, our immune system stands as our frontline defense, producing antibodies to identify and neutralize foreign invaders. For decades, medical science has harnessed the power of antibodies for therapeutic purposes, typically through injections or intravenous administration. However, a groundbreaking innovation has emerged in the form of Immunade - the world's only natural oral antibodies, heralding a new era in immune support and treatment.
The journey towards developing orally administered antibodies began in 1997, culminating in a significant milestone with the registration of the world's first oral antibody veterinary biologic treatment for E. coli bacteria in baby pigs in 2007. Since then, Immunade has continued to advance, currently undergoing phase 2 clinical trials for its oral dose treatment of C. difficile bacterial infection in humans. This remarkable achievement is backed by patented technology and over twenty-five years of dedicated research.
But why antibodies? These large Y-shaped proteins are the cornerstone of our immune system, essential for identifying and neutralizing pathogens. They are the guardians of life, enabling organisms to survive in a world teeming with potential threats. Immunade capitalizes on the power of antibodies, offering a natural solution to bolster immune defenses.
What sets Immunade apart is its natural origin. Unlike synthetic counterparts, Immunade harnesses the concept of passive immunity, where maternal antibodies are transferred to offspring. This natural production process ensures that Immunade remains in harmony with the body's own immune mechanisms, providing a gentle yet potent defense against invading pathogens.
Moreover, Immunade is formulated with dextrose, a monosaccharide sugar known for its quick energy-boosting properties. Acting as a rapid source of energy, dextrose ensures that Immunade swiftly replenishes vital resources, empowering the body to combat threats effectively.
The most intriguing aspect of Immunade lies in its oral administration. Traditionally, antibodies are administered through injections or intravenous infusions due to their inability to survive digestion. However, Immunade defies convention with its natural buffers, allowing antibodies to reach the gut intact. It is within the gut that Immunade's antibodies unleash their protective prowess, safeguarding against pathogens and bolstering overall immune function.
This oral delivery method not only enhances convenience but also offers a more cost-effective alternative to conventional antibody therapies. Monoclonal antibodies, often administered via injection or infusion, come with exorbitant costs, sometimes reaching up to $100,000 per patient per year. Immunade's natural approach not only eliminates the need for invasive procedures but also reduces financial burdens, making immune support more accessible to all.
Immunade represents a paradigm shift in immune support and treatment, harnessing the power of nature to combat pathogens effectively. With its natural origin, oral administration, and cost-effective nature, Immunade holds the promise of revolutionizing how we approach immune health. As we continue to navigate a world fraught with infectious threats, Immunade stands as a beacon of hope, offering a safer, more accessible solution to bolster our defenses and safeguard our well-being.